spacer
home > pmps > winter 2003 > the ultimate solution for reducing medication errors
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Ultimate Solution for Reducing Medication Errors

Are the right patients receiving the right drugs in the right dosage at the right time? Preventing medication errors is high on the agenda not only of hospitals, but the pharmaceutical wholesalers, the pharmaceutical industry and also governments worldwide. The American health care sector is focusing on minimising errors in administering medication. By scanning medication at the patient's bedside, errors can be reduced by as much as 50 per cent or more according to the Federal Drug Administration (FDA). It is no wonder therefore that in mid-2003, the FDA ruled that there should be bar codes on each unit dose. Much research is carried out in order to calculate the percentage of medication errors occurring. Just about every country worldwide has done at least one research project on this subject.

Depending on which research report you read (and depending on the definition of medication error used) the percentage of medication errors varies between 10 and 25 per cent. Almost 0.5 per cent result in permanent injury and 0.25 per cent of patients die due to the wrong medicine or wrong dosage being administered. Although it looks like a small percentage in relation to the size of the population, this number is unacceptable. In addition, the costs of recovery, such as the expense of contra-medication and an extra stay in hospital, are estimated to be an annual ˆ300 million in countries such as The Netherlands. These figures are worrying, especially if you have ever been a patient, and solutions must be found.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Eric Tjoa, CEO at Tjoapack BV

Eric Tjoa founded TjoaPack, a pharmaceutical contract packaging company, in 1989. He holds a Masters in Pharmacy and has given several national and international presentations concerning bar coding and standardisation of unit dose packages, amongst other subjects, at the University of the Western Cape, the EAN conferences in 2002 and 2003, and at the EAHP 1999 in Nice.

spacer
Eric Tjoa
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

EXCLUSIVE: Teva UK launch DuoResp Spiromax and provide update at COPD 2014

The UK launch of Teva’s new DuoResp Spiromax inhaler, intended for adult patients with asthma or COPD, was announced last week following a positive UK court ruling. It addresses a number of key healthcare needs, as asthma and COPD affect an estimated 9.1 million people between them in the UK.*
More info >>

White Papers

Tightening Your Supply Chain Against Counterfeits

World Courier

As today’s global pharmaceutical supply chain grows increasingly longer and more complex, each link provides added opportunity for counterfeiters. While pending regulatory changes promise to tighten the supply chain with respect to production and distribution entities and new packaging technologies will make the identification of counterfeit products easier, the logistics of global distribution remains a weak link. How can the pharmaceutical shipper ensure the security of the supply chain over thousands of miles and extended periods of time when the product is no longer in his possession?
More info >>

 
Industry Events

Cold Chain Distribution

2-3 December 2014, Marriott Regents Park Hotel, London, UK

Join 9th annual Cold Chain Distribution event and be part of a major networking opportunity providing intimate interaction with your peers, where you will hear case studies, presentations and round table discussions on the key issues surrounding the global healthcare cold chain distribution process and logistic requirements for various temperature sensitive healthcare products. 
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement